Report
Valens Research

EL - Embedded Expectations Analysis - 2020 07 08

The Estée Lauder Companies Inc. (EL:USA) currently trades near historical highs relative to UAFRS-based (Uniform) earnings, with a 38.0x Uniform P/E, implying bullish expectations for the firm. However, management may be concerned about travel sales declines, store closures, and their innovation capabilities

Specifically, management may lack confidence in their ability to sustain revenue growth in China, fine-tune their business strategies, and maintain personalized services and curated and targeted communication for La Mer. Moreover, they may have concerns about retail store closures in Europe, the Middle East and Africa, declines in travel consumer traffic around the world, and their share repurchase activity. Furthermore, they may lack confidence in their ability to improve travel retail sales, pursue innovation in Asia, and execute their brand loyalty innovation plan. Finally, they may be exaggerating the productivity of brick-and-mortar stores that can survive the downturn and their ability to strengthen their organization in the long term
Underlying
Estee Lauder Companies Inc. Class A

Estee Lauder Companies is a manufacturer and marketer of skin care, makeup, fragrance and hair care products. The company's products are sold under a number of brand names including: Estee Lauder, Clinique, Origins, MzAzC, Bobbi Brown, La Mer, Jo Malone London, Aveda and Too Faced. The company is also the global licensee for fragrances, cosmetics and/or related products sold under various designer brand names. The company's products include skin care, makeup and related items such as compacts, brushes and other makeup tools, fragrance sold in various forms, hair care, and other ancillary products and services.

Provider
Valens Research
Valens Research

In 2009, just as the dust was settling from the last major equity and credit market crises, we launched a boutique research firm with the intention of breaking Wall Street’s biases and broken incentives:

  • GAAP and IFRS have failed to provide rules for reliable financial statement reporting
  • Stock analyst recommendations are not grounded in disciplined financial analysis
  • Credit agencies have been set up to grossly fail in their responsibilities to investors and the public markets
  • Utter lack of willingness of major research firms to employ the the most advanced forensic analysis available

We sought to provide investors and company analysts with a source of information that changed all that.
Many years later, our business model remains because little has changed on Wall Street.

  • Corporate credit ratings remain years behind the fundamental underpinnings of company performance
  • Stock analysts continue to make recommendations with deeply inherent biases
  • Research firms have failed to break down the walls between credit, equity, and macroeconomic research
  • The governing accounting bodies have created more leeway for mis-estimates and mis-classifications as financials have become unwieldy and overwhelming

The integrity of Valens Research is founded in our disciplined processes and analytics. No “star” analysts. No corporate advisory relationships. No-nonsense opinions and recommendations.

Analysts
Valens Research

Other Reports on these Companies
Other Reports from Valens Research

ResearchPool Subscriptions

Get the most out of your insights

Get in touch